from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3458c/rpsD

LFCtreatmentdescriptionclass of inhibitor

-1.137

Amikacinug/mL Amikacintranslation

0.167

Cap5-10ug/mL Capreomycintranslation

-1.139

Rox10-50 ug/mL Roxithromycintranslation

0.756

SM2-5 ug/mL Streptomycintranslation

0.674

Tet5-10 ug/mL Tetracyclinetranslation

-0.691

Rif0.2-5ug/mL Rifampicintranscription

-1.024

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.286

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.027

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.052

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.011

Clofazimine10-13 ug/mL Clofaziminerespiration

0.195

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.966

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.348

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.813

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.010

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.173

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.403

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.767

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.355

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.640

KCN5-20 ug/mL Potassium cyaniderespiration

-0.883

NaN30.2-2 mM Sodium aziderespiration

0.466

Nigericin50 uM Nigericinrespiration

-1.403

TRC10-150 ug/mL Triclosanrespiration

-1.401

TRZ10-25 ug/mL Thioridazinerespiration

1.586

Valinomycin0.5-10 uM Valinomycinrespiration

0.375

ZnSO42 mM ZnSO4respiration

0.271

menadione6-10 ug/mL Menadionerespiration

0.232

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.581

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.785

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.608

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.053

NRP_1Non-replicating persistence stage 1dosRassociated

0.972

Amp0.2mg/mL AmpicillincellWall

0.692

Cephalexin20-100 ug/mL CephalexincellWall

0.350

Cerulenin0.32-5 ug/mL CerulenincellWall

1.083

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.343

EMB10-20 ug/mL EthambutolcellWall

0.051

Eta12-40 ug/mL EthionamidecellWall

0.671

INH0.2-0.4 ug/mL IsoniazidcellWall

0.325

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.226

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.666

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.813

BZA0.12 mg/mL BenzamidearomaticAmides

0.030

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.117

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.240

H2O24 mM hydrogen peroxideDNAdamaging

0.503

Levo10 ug/mL LevofloxacinDNAdamaging

0.862

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.245

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.822

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.594

UVUV-irradiationDNAdamaging

1.121

ARP41-4 ug/mL Antitubercular compound ARP4?

0.579

Antimycin12.5-50 ug/mL Antimycin A?

0.501

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.584

PA_110-50 ug/mL Antitubercular compound PA-1?

0.657

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.365

PA8240.2-2 ug/mL PA-824?

-0.883

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.482

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.098

Verapamil50 uM Verapamil?

0.473

mercaptoethanol2 mM 2-Mercaptoethanol?

0.393

methoxatin10-20 ug/mL Methoxatin?